Dopamine Agonists and Risk of Lung Cancer in Patients with Restless Legs Syndrome.

Pilar Hernandez-Con Justine Shults Allison W Willis Yu-Xiao Yang

Published in: Pharmacoepidemiology and drug safety (2023)

At typical doses for the clinical management of RLS, long-term DA use was not associated with risk of lung cancer. This article is protected by copyright. All rights reserved.

Keyphrases

case report